Fundraising FoxFREZENT Biological Solutions
1 known investors
Find your way into FREZENT Biological Solutions
Sign up to see every warm intro you have to FREZENT Biological Solutions
- Paths you didn't know you had: your email and LinkedIn already hold routes to the FREZENT Biological Solutions team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Frezent develops next-generation antibody biologics that target both dividing and dormant cancer cells to eliminate minimal residual disease and prevent cancer recurrence. It applies AI tools to optimize its antibodies and integrates its treatment with standard of care in oncology.
Founders & leadership
NS
Natasha ShtraizentCo-founder & CEO
Investors · 1
Frequently asked questions
- What does FREZENT Biological Solutions do?
- Frezent develops next-generation antibody biologics that target both dividing and dormant cancer cells to eliminate minimal residual disease and prevent cancer recurrence. It applies AI tools to optimize its antibodies and integrates its treatment with standard of care in oncology.
- Who are FREZENT Biological Solutions's investors?
- FREZENT Biological Solutions's investors include SOSV.